Apotex, in collaboration with Orbicular Pharmaceutical Technologies Pvt. Ltd. and Gland Pharma Limited, today announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated ...

TORONTO, April 23, 2026 /PRNewswire/ - Apotex, the largest Canadian based pharmaceutical company, and Cumberland Pharmaceuticals Inc. ("Cumberland"), a U.S. based specialty pharmaceutical company, ...

On March 11, 2020, the Federal Court of Appeal dismissed Apotex’s appeal of the Federal Court’s decision ordering Apotex to pay over $61M from an accounting of profits from Apotex’s infringement of ...

U.S. market will not open until patent expires in 2032, but individual generics can be sold in Canada once approved ...

The FDA approves Apotex Corp.’s plan to introduce generic Ozempic, a semaglutide injection that one study suggests could ...

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) shares surged 80% on Thursday after the company announced a strategic deal with ...

TORONTO, Jan. 9, 2025 /PRNewswire/ - Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, today announced that its affiliate Nuvo Pharmaceuticals (Ireland) DAC has acquired the ...

Case Name: Horizon Medicines LLC v. Apotex Inc., Civ. No. 22-640-CJB, 2022 WL 16739909 (D. Del. Nov. 7, 2022) (Burke, M.J.) Drug Product and Patent(s)-in-Suit ...

Pfizer sued generic drug maker Apotex on June 20 in Delaware District Court over alleged patent infringement of its breast cancer drug Ibrance. The lawsuit, brought by Williams & Connolly and Morris ...

Apotex Inc. and Apotex Corp. were hit with a patent infringement lawsuit on Dec. 10 in Delaware District Court over their attempt to market a generic version of the pulmonary arterial hypertension ...

TORONTO, March 20, 2020 /CNW/ - Apotex, Canada's largest pharmaceutical company, announced today that it is donating Hydroxychloroquine to accelerate a study examining if it prevents infection of ...